Characterization of the ATPase cycle of human ABCA1:: Implications for its function as a regulator rather than an active transporter

被引:43
作者
Szakács, G
Langmann, T
Özvegy, C
Orsó, E
Schmitz, G
Váradi, A
Sarkadi, B
机构
[1] Hungarian Acad Sci, Natl Inst Haematol & Immunol, Membrane Res Grp, H-1113 Budapest, Hungary
[2] Univ Regensburg, Inst Clin Chem & Lab Med, D-93042 Regensburg, Germany
[3] Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary
基金
匈牙利科学研究基金会;
关键词
human ABCA1; membrane protein; Baculovirus-insect cell expression system; ATP binding; ATPase activity; nucleotide occlusion; cholesterol and lipid metabolism;
D O I
10.1006/bbrc.2001.5905
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ABCA1 plays a key role in cellular cholesterol and phospholipid traffic. To explore the biochemical properties of this membrane protein we applied a Baculovirus-insect cell expression system. We found that human ABCA1 in isolated membranes showed a specific, Mg2+-dependent ATP binding but had no measurable ATPase activity. Nevertheless, conformational changes in ABCA1 could be demonstrated by nucleotide occlusion, even without arresting the catalytic cycle by phosphate-mimicking anions. Addition of potential lipid substrates or lipid acceptors (apolipoprotein A-I) did not modify the ATPase activity or nucleotide occlusion by ABCA1. Our data indicate that ATP hydrolysis by ABCA1 occurs at a very low rate, suggesting that ABCA1 may not function as an effective active transporter as previously assumed. In the light of the observed conformational changes we propose a regulatory function for human ABCA1. (C) 2001 Academic Press.
引用
收藏
页码:1258 / 1264
页数:7
相关论文
共 38 条
[1]   Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator [J].
Aleksandrov, L ;
Mengos, A ;
Chang, XB ;
Aleksandrov, A ;
Riordan, JR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :12918-12923
[2]  
Bakos É, 2000, J CELL SCI, V113, P4451
[3]   Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain [J].
Bakos, E ;
Evers, R ;
Szakács, G ;
Tusnády, GE ;
Welker, E ;
Szabó, K ;
de Haas, M ;
van Deemter, L ;
Borst, P ;
Váradi, A ;
Sarkadi, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :32167-32175
[4]   ABC1, an ATP binding cassette transporter required for phagocytosis of apoptotic cells, generates a regulated anion flux after expression in Xenopus laevis oocytes [J].
Becq, F ;
Hamon, Y ;
Bajetto, A ;
Gola, M ;
Verrier, B ;
Chimini, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (05) :2695-2699
[5]   The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease [J].
Bodzioch, M ;
Orsó, E ;
Klucken, T ;
Langmann, T ;
Böttcher, L ;
Diederich, W ;
Drobnik, W ;
Barlage, S ;
Büchler, C ;
Porsch-Özcürümez, M ;
Kaminski, WE ;
Hahmann, HW ;
Oette, K ;
Rothe, G ;
Aslanidis, C ;
Lackner, KJ ;
Schmitz, G .
NATURE GENETICS, 1999, 22 (04) :347-351
[6]   The multidrug resistance protein family [J].
Borst, P ;
Evers, R ;
Kool, M ;
Wijnholds, J .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1461 (02) :347-357
[7]   ABC transporters in lipid transport [J].
Borst, P ;
Zelcer, N ;
van Helvoort, A .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1486 (01) :128-144
[8]   The ABCA subclass of mammalian transporters [J].
Broccardo, C ;
Luciani, MF ;
Chimini, G .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1461 (02) :395-404
[9]   Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency [J].
Brooks-Wilson, A ;
Marcil, M ;
Clee, SM ;
Zhang, LH ;
Roomp, K ;
van Dam, M ;
Yu, L ;
Brewer, C ;
Collins, JA ;
Molhuizen, HOF ;
Loubser, O ;
Ouelette, BFF ;
Fichter, K ;
Ashbourne-Excoffon, KJD ;
Sensen, CW ;
Scherer, S ;
Mott, S ;
Denis, M ;
Martindale, D ;
Frohlich, J ;
Morgan, K ;
Koop, B ;
Pimstone, S ;
Kastelein, JJP ;
Genest, J ;
Hayden, MR .
NATURE GENETICS, 1999, 22 (04) :336-345
[10]   Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease [J].
Brousseau, ME ;
Bodzioch, M ;
Schaefer, EJ ;
Goldkamp, AL ;
Kielar, D ;
Probst, M ;
Ordovas, JM ;
Aslanidis, C ;
Lackner, KJ ;
Rubins, HB ;
Collins, D ;
Robins, SJ ;
Wilson, PWF ;
Schmitz, G .
ATHEROSCLEROSIS, 2001, 154 (03) :607-611